Verona Pharma plc Quarterly Liabilities, Current in USD from Q4 2019 to Q4 2024

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Verona Pharma plc quarterly Liabilities, Current history and growth rate from Q4 2019 to Q4 2024.
Verona Pharma plc Liabilities, Current for the quarter ending December 31, 2024 was $42.7M, a 391% increase year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2024	$42.7M	+$34M	+391%	Dec 31, 2024	10-K	2025-02-27
Q3 2024	$28M	+$18.9M	+210%	Sep 30, 2024	10-Q	2024-11-04
Q2 2024	$48.3M	+$37.4M	+342%	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$14.8M	-$11.7M	-44.3%	Mar 31, 2024	10-Q	2024-05-10
Q4 2023	$8.69M	-$10.3M	-54.3%	Dec 31, 2023	10-K	2025-02-27
Q3 2023	$9.01M	-$23.1M	-72%	Sep 30, 2023	10-Q	2023-11-02
Q2 2023	$10.9M	-$27.9M	-71.8%	Jun 30, 2023	10-Q	2023-08-03
Q1 2023	$26.5M	-$11.4M	-30%	Mar 31, 2023	10-Q	2023-05-09
Q4 2022	$19M	-$14.4M	-43.1%	Dec 31, 2022	10-K	2024-02-29
Q3 2022	$32.1M	+$4.39M	+15.8%	Sep 30, 2022	10-Q	2022-11-09
Q2 2022	$38.9M	-$19.5M	-33.4%	Jun 30, 2022	10-Q	2022-08-09
Q1 2022	$37.9M	+$25.2M	+198%	Mar 31, 2022	10-Q	2022-05-03
Q4 2021	$33.4M	+$19.2M	+135%	Dec 31, 2021	10-K	2023-03-07
Q3 2021	$27.7M			Sep 30, 2021	10-Q	2021-11-09
Q2 2021	$58.4M			Jun 30, 2021	10-Q	2021-08-05
Q1 2021	$12.7M			Mar 31, 2021	10-Q	2021-04-29
Q4 2020	$14.2M	+$1.36M	+10.6%	Dec 31, 2020	10-K	2022-03-03
Q4 2019	$12.8M			Dec 31, 2019	10-K	2021-02-25

* An asterisk sign (*) next to the value indicates that the value is likely invalid.